大型女性队列中甲状腺功能亢进、甲状腺功能减退与病因特异性死亡率
这项前瞻性队列纳入75,076名美国女性放射技师,随访近30年,比较自报甲状腺功能状态与病因特异性死亡风险。作者认为这些超额死亡风险需重复验证并进一步研究。
核心结论
- 其他死因与甲亢或甲减无关,但甲亢女性卵巢癌死亡风险有升高提示,基于极少数病例。
- 作者认为观察到的超额死亡风险需重复验证,若可重复则因临床意义需进一步研究。
研究设计与样本
- 前瞻性队列研究,纳入75,076名20-89岁美国女性放射技师,1926-1982年认证,1983-1998年完成基线问卷获取病史,排除恶性肿瘤或良性甲状腺疾病(甲状腺功能异常除外)。
- 通过社会保障管理局数据库和National Death Index-Plus进行被动随访,采用比例风险模型比较自报甲状腺状态与病因特异性死亡风险,调整基线年份和年龄、种族/民族、体重指数、乳腺癌家族史及生活方式和生殖因素。
主要发现
- 中位随访28年,记录2609例癌症死亡、1789例心血管或脑血管死亡、2442例其他非癌症死亡。
- 其他死因与甲亢或甲减无关,但甲亢女性卵巢癌死亡风险有升高提示,基于极少数病例。
局限性
- 作者指出观察到的超额死亡风险需重复验证,若可重复则因临床意义需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of hyperthyroidism and hypothyroidism is 0.5-4% in iodine-replete communities, but it is 5-10 times higher in women than in men. Those conditions are associated with a broad range of metabolic disorders and cardiovascular diseases. Biological evidence of a role of thyroid hormones in carcinogenesis also exists. However, the association between thyroid dysfunction and cardiovascular disease or cancer mortality risk remains controversial. In a large cohort of women, the associations of hyperthyroidism and hypothyroidism with cause-specific mortality were evaluated after nearly 30 years of follow-up. METHODS: The prospective study included 75,076 women aged 20-89 years who were certified as radiologic technologists in the United States in 1926-1982, completed baseline questionnaires in 1983-1998 from which medical history was ascertained, and reported no malignant disease or benign thyroid disease except thyroid dysfunction. A passive follow-up of this cohort was performed through the Social Security Administration database and the National Death Index-Plus. Cause-specific mortality risks were compared according to self-reported thyroid status, with proportional hazards models adjusted for baseline year and age, race/ethnicity, body mass index, family history of breast cancer, and life-style and reproductive factors. RESULTS: During a median follow-up of 28 years, 2609 cancer, 1789 cardiovascular or cerebrovascular, and 2442 other non-cancer deaths were recorded. Women with hyperthyroidism had an elevated risk of breast cancer mortality after 60 years of age (hazard ratio [HR] = 2.04 [confidence interval (CI) 1.16-3.60], 13 cases in hyperthyroid women) compared to women without thyroid disease. Hypothyroid women had increased mortality risks for diabetes mellitus (HR = 1.58 [CI 1.03-2.41], 27 cases in hypothyroid women), cardiovascular disease (HR = 1.20 [CI 1.01-1.42], 179 cases), and cerebrovascular disease (HR = 1.45 [CI 1.01-2.08], 35 cases, when restricting the follow-up to ≥10 years after baseline). Other causes of death were not associated with hyperthyroidism or hypothyroidism, though there was a suggestion of an elevated risk of ovarian cancer mortality in hyperthyroid women based on very few cases. CONCLUSION: The excess mortality risks observed in a large, prospective 30-year follow-up of patients with thyroid dysfunction require confirmation, and, if replicated, further investigation will be needed because of the clinical implications.
引用
- Journy NMY, Bernier MO, Doody MM, et al. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women. Thyroid. 2017. PMID: 28578598. doi:10.1089/thy.2017.0063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。